SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,523 INR | +0.42% |
|
-5.07% | +20.91% |
Chart calendar Sun Pharmaceutical Industries Ltd.
71b0f841f963a9cf6b8c7d86ea.mVUL6xBg3p8pyxHBR4L_Mqgy3uDgXHNWabgdvwv4IcM.qSJCjHkj86l9-2TxHe-xd8B6uqXZawE3Xc9b70qaTKX-Jz-MVxms-h2kKQ~6d290343404e356980b5a2e6a1cf8314
Upcoming events on Sun Pharmaceutical Industries Ltd.
Past events on Sun Pharmaceutical Industries Ltd.
| 2024-03-10 | Citi India Investor Conference |
| 2024-02-19 | Antique Build India New India Conference |
| 2024-02-18 | Kotak Chasing Growth Conference |
| 2024-02-13 | Axis Capital India Conference |
| 2024-02-12 | IIFL Enterprising India Global Investors Conference |
| 2024-02-11 | Nuvama India Conference |
| 2024-02-08 | Ex-dividend day for dividende intermédiaire |
| 2024-01-31 08:00 am | Q3 2024 Earnings Call |
| 2024-01-31 03:43 am | Q3 2024 Earnings Release |
| 2023-11-30 | B&K Indian INC Leaders Conference |
| 2023-11-29 | CITIC CLSA India Forum |
| 2023-11-21 | JM Financial India Conference |
| 2023-11-20 | Nirmal Bang Investor Conference |
| 2023-11-01 09:00 am | Q2 2024 Earnings Call |
| 2023-11-01 03:53 am | Q2 2024 Earnings Release |
| 2023-09-25 | Kotak Institutional Equities Healthcare Forum |
| 2023-09-24 | J.P. Morgan India Investor Summit |
| 2023-09-21 | Investor Meeting |
| 2023-09-04 | Ashwamedh Elara India Dialogue Conference |
| 2023-09-03 | ICICI Securities Healthcare Conference |
Past dividends on Sun Pharmaceutical Industries Ltd.
| 2024-02-08 | Interim Payment 8.5 INR |
| 2023-07-27 | Final Payment 4 INR |
| 2023-02-07 | Interim Payment 7.5 INR |
| 2022-08-18 | Final Payment 3 INR |
| 2022-02-08 | Interim Payment 7 INR |
| 2021-08-22 | Final Payment 2 INR |
| 2021-02-08 | Interim Payment 5.5 INR |
| 2020-08-18 | Final Payment 1 INR |
| 2020-02-16 | Interim Payment 3 INR |
| 2019-08-19 | Annual 2.75 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 290 659 297 010 -2.14% | 328 375 326 146 0.68% | 334 981 339 116 -1.22% | 386 545 387 674 -0.29% | 438 857 437 615 0.28% | 485 375 |
|
EBITDA Million INR | Released Forecast Spread | 63 076 67 804 -6.97% | 69 898 72 178 -3.16% | 84 914 85 303 -0.46% | 103 977 104 798 -0.78% | 116 468 116 735 -0.23% | 130 469 |
|
EBIT Million INR | Released Forecast Spread | 45 543 50 242 -9.35% | 49 370 53 916 -8.43% | 64 114 65 515 -2.14% | 82 540 83 007 -0.56% | 91 174 92 955 -1.92% | 105 587 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 38 102 50 892 -25.13% | 50 096 57 517 -12.9% | 27 994 46 090 -39.26% | 44 813 88 719 -49.49% | 94 084 96 486 -2.49% | 111 497 |
|
Net income Million INR | Released Forecast Spread | 26 654 29 846 -10.7% | 37 649 43 229 -12.91% | 29 038 37 004 -21.53% | 32 727 73 141 -55.25% | 84 736 84 823 -0.1% | 93 029 |
|
EPS INR | Released Forecast Spread | 11,1 12,0 -7.59% | 15,7 18,0 -12.74% | 12,1 17,4 -30.46% | 13,6 31,0 -56.12% | 35,3 35,3 -0.08% | 39,1 |
| Announcement Date | 28/05/19 | 27/05/20 | 27/05/21 | 30/05/22 | 26/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 85 230 87 214 -2.28% | 97 187 88 100 10.32% | 96 259 94 501 1.86% | 98 631 96 288 2.43% | 94 468 95 675 -1.26% | 107 618 102 988 4.5% | 109 523 109 076 0.41% | 112 410 111 306 0.99% | 109 307 109 032 0.25% | 119 408 116 943 2.11% | 120 786 | 122 741 | 122 314 | 127 397 |
|
EBITDA Million INR | Released Forecast Spread | 20 484 21 509 -4.76% | 28 211 21 644 30.34% | 26 299 24 263 8.39% | 26 063 25 283 3.09% | 23 404 24 606 -4.88% | 28 844 25 419 13.47% | 29 566 28 291 4.51% | 30 037 30 145 -0.36% | 28 021 27 584 1.59% | 33 318 29 996 11.07% | 32 390 | 33 096 | 31 960 | |
|
EBIT Million INR | Released Forecast Spread | 14 950 15 687 -4.7% | 23 179 16 456 40.85% | 20 996 18 632 12.69% | 20 527 19 353 6.06% | 17 839 18 818 -5.2% | 22 964 18 663 23.05% | 23 466 21 614 8.57% | 23 438 23 178 1.12% | 21 306 21 939 -2.88% | 26 805 22 032 21.66% | 23 673 | 27 405 | 24 544 | 26 836 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 9 030 17 329 -47.89% | 18 042 18 426 -2.08% | 22 865 20 094 13.79% | 24 662 21 865 12.79% | -20 756 20 974 -198.96% | 22 848 19 886 14.9% | 24 124 23 853 1.14% | 24 715 25 559 -3.3% | 22 397 21 454 4.4% | 24 811 23 953 3.58% | 26 568 | 27 807 | 28 313 | |
|
Net income Million INR | Released Forecast Spread | 8 942 14 937 -40.14% | 14 442 15 111 -4.43% | 20 470 16 944 20.81% | 20 588 18 397 11.91% | -22 773 17 449 -230.51% | 20 609 17 087 20.61% | 22 622 20 430 10.73% | 21 660 21 459 0.93% | 19 845 19 517 1.68% | 20 225 21 481 -5.85% | 23 123 | 24 062 | 23 542 | |
|
EPS INR | Released Forecast Spread | 3,70 8,89 -58.4% | 6,00 6,49 -7.48% | 8,60 6,75 27.41% | -9,50 7,30 -230.14% | 8,60 8,22 4.62% | 9,40 8,22 14.36% | 9,00 8,70 3.5% | 8,30 7,92 4.75% | 8,40 8,23 2.02% | 8,65 | 9,79 | 9,80 | ||
| Announcement Date | 27/05/21 | 30/07/21 | 02/11/21 | 31/01/22 | 30/05/22 | 29/07/22 | 01/11/22 | 31/01/23 | 26/05/23 | 03/08/23 | - | - | - | - |
More events
Past sector events for Sun Pharmaceutical Industries Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SUNPHARMA Stock
- Calendar Sun Pharmaceutical Industries Ltd.
